dabo
Selected indexed studies
- Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. (Lancet, 2023) [PMID:37356446]
- "Code Headache": Development of a protocol for optimizing headache management in the emergency room. (Eur J Neurol, 2024) [PMID:39287050]
- An Amazing 30-Year Journey around the DABO Family: A Medicinal Chemistry Lesson on a Versatile Class of Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. (J Med Chem, 2025) [PMID:40053382]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023. (2025) pubmed
- Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. (2025) pubmed
- Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. (2023) pubmed
- "Code Headache": Development of a protocol for optimizing headache management in the emergency room. (2024) pubmed
- An Amazing 30-Year Journey around the DABO Family: A Medicinal Chemistry Lesson on a Versatile Class of Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. (2025) pubmed
- Design of novel DABO derivatives as HIV-1 RT inhibitors using molecular docking, molecular dynamics simulations and ADMET properties. (2024) pubmed
- The development of HEPT-type HIV non-nucleoside reverse transcriptase inhibitors and its implications for DABO family. (2012) pubmed
- Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase. (2006) pubmed
- Global, regional, and national burden of HIV/AIDS, 1990-2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021. (2024) pubmed
- Comparative effectiveness of daptomycin versus vancomycin among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: A systematic literature review and meta-analysis. (2024) pubmed